At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> SEC Filings

SEC Filings

  
Filing Description Date Filed Sorted Descending Size View  
4 valenzano, ken Apr 17, 2015 24.9 KB View HTML View PDF View XLS  
4 sblendorio, glenn Apr 17, 2015 25.6 KB View HTML View PDF View XLS  
PRE 14A preliminary proxy statement Apr 13, 2015 741.6 KB View HTML View PDF View XLS  
8-K current report Apr 13, 2015 22.7 KB View HTML View PDF View XLS  
4 crowley, john f Apr 13, 2015 26.3 KB View HTML View PDF View XLS  
4 castelli, jeff Apr 2, 2015 27.5 KB View HTML View PDF View XLS  
4 do, hung Mar 27, 2015 24.4 KB View HTML View PDF View XLS  
4 valenzano, ken Mar 25, 2015 28.0 KB View HTML View PDF View XLS  
4 yu, julie Mar 25, 2015 27.5 KB View HTML View PDF View XLS  
4 valenzano, ken Mar 24, 2015 27.5 KB View HTML View PDF View XLS  
4 peist, kenneth Mar 24, 2015 27.4 KB View HTML View PDF View XLS  
4 kirk, john Mar 24, 2015 26.5 KB View HTML View PDF View XLS  
4 gershkowitz, jayne Mar 24, 2015 27.4 KB View HTML View PDF View XLS  
4 dilone, enrique Mar 24, 2015 29.1 KB View HTML View PDF View XLS  
4 crowley, john f Mar 24, 2015 27.5 KB View HTML View PDF View XLS  
4 campbell, bradley l Mar 24, 2015 27.5 KB View HTML View PDF View XLS  
4 baird, william d iii Mar 24, 2015 28.5 KB View HTML View PDF View XLS  
SC 13D/A amended general statement of beneficial ownership Mar 24, 2015 49.8 KB View HTML View PDF View XLS  
S-3 registration statement Mar 3, 2015 550.1 KB View HTML View PDF View XLS  
10-K annual report Mar 3, 2015 1.0 MB View HTML View PDF View XLS View XBRL  
Showing 1-20 of 862 Page: 1 2 3 4 5 ... 44  Next 20

Copyright © 2015 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy